Write your message

  Volume 14, Issue 4 (Iranian Journal of Breast Disease 2022)  

View This Issue in Alternative Language Export Journal XML Articles RSS
Iranian Quarterly Journal of Breast Disease
Abstract (4476 Views) | چکیده  |   Full-Text (PDF) (2246 Downloads)   |   Highlights
Conclusion: EFT can be used as an appropriate intervention to reduce depression and increase self-compassion significantly and enduringly in women with breast cancer.


Abstract (2619 Views) | چکیده  |   Full-Text (PDF) (1268 Downloads)   |   Highlights
Conclusion: The results showed that salivary HSP70 levels were not significantly different between patients with breast cancer and healthy individuals, and according to the ROC curve, the salivary level of this protein has no diagnostic value in these patients.


Abstract (6476 Views) | چکیده  |   Full-Text (PDF) (2340 Downloads)   |   Highlights
Conclusion: The results of the study indicate that the survival of breast cancer patients in diabetics is not significantly different from non-diabeticsUse of metformin and estrogen receptor positivity is associated with higher 5-year survival rates in women with breast cancer. Therefore, cancer screening programs in high-risk groups, especially in diabetic patients, and hyperglycemic control may affect survival time.


Abstract (3408 Views) | چکیده  |   Full-Text (PDF) (1350 Downloads)   |   Highlights
Conclusion: Our findings suggest that miRNA-145, by targeting the PD1/PD-L1 pathway and reducing PD-L1 expression, may be a therapeutic agent to prevent the progression of breast cancer.


Abstract (3580 Views) | چکیده  |   Full-Text (PDF) (1029 Downloads)   |   Highlights
Conclusion: Theory-based educational planning to encourage women to adopt breast cancer-preventive behaviors, including a healthy lifestyle and screening behaviors, is essential.


Abstract (5508 Views) | چکیده  |   Full-Text (PDF) (3139 Downloads)   |   Highlights
Conclusion: Although the results of this study are helpful for policymakers and therapists, it is better to make decisions based on the results of effectiveness and cost in Iran.


Iranian Journal of Breast Disease

Export as: HTML | XML | RSS

© 2025 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb